超越皮肤:与婴儿亚托皮炎相关的肺功能下降
Zeynep Gulec Koksal1, Pinar Uysal1
1Department of Pediatric Allergy and Immunology, Aydin Adnan Menderes University Faculty of Medicine, Aydin, Turkey.
概括
潮呼吸分析 (TBA) 显示,亚托皮性皮肤炎 (AD) 患婴儿的肺功能下降,这表明早期的气道阻塞. 这种方法显示出对AD儿童客观临床评估的希望.
科学领域:
- 儿科肺病学 儿科肺病学
- 皮肤病学 皮肤病学
- 过敏 免疫学 免疫学
背景情况:
- 亚托邦性皮肤炎 (AD) 与患喘的风险更高有关.
- 患有阿尔茨海默症的婴儿肺功能评估尚未得到充分研究.
- 潮呼吸分析 (TBA) 提供了一种评估这一群体肺功能的潜在方法.
研究的目的:
- 用TBA测量患有AD的婴儿和健康的对照 (HCs) 的肺功能.
- 调查AD严重程度,食物敏感性和经常性喘息对TBA参数的影响.
- 评估TBA在检测患有AD的婴儿呼吸道阻塞方面的实用性.
主要方法:
- 一项涉及230名婴儿 (150名患有AD,80名HC) 的前性横截面研究.
- 肺功能通过TBA进行评估.
- 疾病严重程度使用SCORing 评估;食物敏感性通过IgE或皮肤刺伤测试来确定.
主要成果:
- 与HC相比,患有AD的婴儿表现出明显较低的TBA参数 (P < .05).
- 关键参数如呼气流和呼吸速率在AD组下降.
- 时间到峰值呼气流与呼气时间的比率有效地区分了AD,具有高灵敏度和特异性 (AUC=0.826).
结论:
- 在患有AD的婴儿中,TBA是识别呼吸道阻塞的宝贵工具.
- 客观的肺功能数据可以通过使用TBA获得临床用途.
- 患有阿尔茨海默病的婴儿的支气管阻塞存在,无论疾病的严重程度或相关因素如何.
更多相关视频
09:32Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
Published on: September 26, 2019
7.2K
05:31Noninvasive Sampling of Mucosal Lining Fluid for the Quantification of In Vivo Upper Airway Immune-mediator Levels
Published on: August 7, 2017
10.4K
相关概念视频
Breathing
59.7K
The process of breathing, inhaling and exhaling, involves the coordinated movement of the chest wall, the lungs, and the muscles that move them. Two muscle groups with important roles in breathing are the diaphragm, located directly below the lungs, and the intercostal muscles, which lie between the ribs. When the diaphragm contracts, it moves downward, increasing the volume of the thoracic cavity and creating more room for the lungs to expand. When the intercostal muscles contract, the ribs...
59.7K
Asthma-I: Introduction
2.7K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.7K
Pulmonary Cycle: Exhalation
1.6K
In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.6K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.9K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.9K
Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
Antiasthma Drugs: Leukotriene Modifiers
369
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
369
